Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999

NCT02393027 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Enough inclusions for interpretation

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG: [18F] LBT-999 PET

Sponsor

University Hospital, Tours